Acute and long-term outcomes of epicardial left atrial appendage ligation with the second-generation LARIAT device: a high-volume electrophysiology center experience.
Thomas FinkMichael SchlüterRoland Richard TilzChristian-Hendrik HeegerChristine LemesTilmann MaurerBruno ReissmannLaura RottnerFrancesco SantoroShibu MathewAndreas RilligFeifan OuyangKarl-Heinz KuckAndreas MetznerPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2018)
Epicardial LAA ligation with the second-generation LARIAT device was associated with a high acute success rate comparable to endocardial LAA closure devices. LAA ligation was accompanied by a relevant incidence of periprocedural complications with mild pericarditis being the most common adverse event. Follow-up demonstrated a moderate incidence of leakages after LAA exclusion, no intracardiac thrombus formation and only a single thromboembolic event. The effectiveness in preventing thromboembolic events needs further investigation in larger patient cohorts.
Keyphrases
- left atrial appendage
- atrial fibrillation
- catheter ablation
- liver failure
- risk factors
- respiratory failure
- direct oral anticoagulants
- aortic dissection
- drug induced
- percutaneous coronary intervention
- randomized controlled trial
- systematic review
- heart failure
- hepatitis b virus
- high intensity
- venous thromboembolism
- coronary artery disease
- left ventricular